- Report
- April 2023
- 147 Pages
Global
From €4351EUR$4,949USD£3,792GBP
- Report
- August 2024
- 110 Pages
Global
From €3472EUR$3,950USD£3,027GBP
- Report
- May 2024
- 130 Pages
Global
From €3472EUR$3,950USD£3,027GBP
- Report
- March 2024
- 249 Pages
Global
€4391EUR$4,995USD£3,827GBP
- Report
- November 2022
- 160 Pages
Global
€2989EUR$3,400USD£2,605GBP
- Report
- October 2023
- 180 Pages
Global
From €1099EUR$1,250USD£958GBP
€2198EUR$2,500USD£1,916GBP
- Report
- October 2023
- 80 Pages
France
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
Germany
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
India
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
United States
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1319EUR$1,500USD£1,149GBP
From €1319EUR$1,500USD£1,149GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1319EUR$1,500USD£1,149GBP
- Report
- September 2025
- 96 Pages
Germany
From €4264EUR$4,850USD£3,716GBP
- Report
- September 2023
- 114 Pages
Global
From €2593EUR$2,950USD£2,260GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2593EUR$2,950USD£2,260GBP
- Report
- September 2023
- 89 Pages
From €2593EUR$2,950USD£2,260GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3033EUR$3,450USD£2,643GBP
- Report
- September 2023
- 112 Pages
Europe
From €3033EUR$3,450USD£2,643GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more